🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I’ve been in the exercise oncology field for 20 years and for all of that time, the main criticism has been “show me a well controlled RCT.” Well, here it is. Exercise following adjuvant chemotherapy for colon cancer reduced recurrence and improves OVERALL SURVIVAL! #ASCO25

BMI analysis of ASCENT. Overweight/obese pts experienced higher rates of serious AEs (34% vs 18%) with SG and 41% of obese pts required dose reduction (vs 10%). Should we cap the dose of SG for overweight/obese pts, similar to other ADCs (eg EV, Dato-DXd)? esmoopen.com/action/consume…

Looking forward to important findings and conversations about environmental exposures (microplastics, chemicals/particles/endocrine disrupters), lifestyle (exercise, diet, stress) and more on cancer risk.

What happens when you query chatGPT with 362 breast cancer cases? -46% responses differed from breast cancer expert opinion -when the same case was entered 3 times, the responses differed ~2/3 of the time ! -for examples, see 🧵..

An honor to receive funding for this work from The V Foundation for Cancer Research for Cancer Research. We hope to be able to better understand how improving metabolic health through exercise or weight loss reduces the risk of cancer. Couldn’t ask for a better partnership!

New updates coming, but first- It’s hard to put into words what this group means to me - mentors, friends, family. I’ve leaned on them, laughed, cried, and grown with them. This isn’t goodbye, just deep gratitude for every moment we shared- and more to come. Memorial Sloan Kettering Cancer Center

Dapiglutide is a first-in-class dual GLP1/GLP2 agonist. A hypothesis is GLP2 agonism can have a unique anti-inflammatory effect. Phase 1 Data presented at #ADA2025 today

Lean body mass–based oxaliplatin dosing reduces peripheral neuropathy in stage III colon cancer without compromising survival! ✅ Lower rates of grade ≥2 oxaliplatin-induced peripheral neuropathy ✅ Better quality of life ✅ No impact on relapse-free survival or overall survival

I am delighted to join Winship Cancer Institute of Emory University as co-director of breast oncology and director of cancer survivorship. Excited to join this team with deep and synergistic expertise where we will continue advancing cutting-edge science at the intersection of metabolic health and cancer!

Thank you MSK Department of Medicine ! I will always carry my Memorial Sloan Kettering Cancer Center experience with me and I look forward to continued collaborations with MSK’s amazing scientists and physicians, who I am fortunate to call friends.

We need nutritional screening in every cancer patient, even normal weight, through body composition & at molecular level. Patients' stratification can help us assess nutritional/metabolic risks of inflammatory implications in cancer #lipidomic npj Journals nature.com/articles/s4152…

How do #nutrition & #diet impact #CancerRisk & outcomes: from childhood to adulthood? Find out at the next IARC - ESMO webinar: “Nutrition, diet & cancer” 🗓️ 22 July 2025, 15:00–16:30 CEST 🔗 Register: ow.ly/EgT450Wnyvz #CancerPrevention #Oncology

ESMO - Eur. Oncology IARC Neil Iyengar, MD For those interested in this important topic, consider submitting to our special issue of JNCI Cancer Spectrum on #exercise, #nutrition, and #cancer outcomes! academic.oup.com/jncics/pages/c… James Yu

The Glenn Family Breast Cancer Center Winship Cancer Institute of Emory University invites you to join the OncLive.com State of the Science Summit on Breast Cancer. Tuesday, July 29, from 6:00-9:00 PM EST. The event features a dinner, networking reception, and prize raffle! Register: registration.onclive.com/soss-breast-at…

Delighted to join on the 25th anniversary of this inspiring meeting showcasing the exciting progress in cancer treatment.

Listening to Dr. Fadlo Khuri deliver a phenomenal keynote. In an expansive review of cancer advances and future: “Dysregulation of metabolism unquestionably leads to cancer. We will see an era where we treat diabetes and cancer etiology together”. #DDHO2025 Winship Cancer Institute of Emory University

Winship breast medical oncologist and director of survivorship services, Neil M. Iyengar, MD, (Neil Iyengar, MD) discusses optimizing survivorship—highlighting strategies to improve quality of life and long-term outcomes for cancer survivors at #DDHO2025.

Absolutely outstanding breast cancer session at #DDHO2025. Major themes included treatment de-escalation strategies, adjuvant advances making cure even more possible, and of course lifestyle guidance. I am so incredibly excited to join the remarkable team at Winship Cancer Institute of Emory University

The breast cancer session at #DDHO2025 concludes with a patient-based panel discussion and Q&A—bringing together expert perspectives and patient-centered insights to close out a day of impactful dialogue.